Monitor for actual execution of the sale on Form 4. The small dollar amount limits immediate downside, but the insider's dual role and the company's negative historical performance pattern suggest caution. Watch for any subsequent insider selling clusters or negative news flow.
Price Chart
Executive Summary
Ali Faraz, an officer and director of Tenaya Therapeutics, filed a Form 144 notice of intent to sell 22,232 shares of common stock, with an estimated aggregate market value of approximately $15,778. The shares were acquired from restricted stock unit vesting. This is a relatively small sale relative to the company's $163M market cap, but the filing by a dual officer/director role carries moderate signaling weight, especially given the company's poor historical stock performance and negative analyst consensus drift.
Key Facts
- Ali Faraz (officer and director) filed Form 144 to sell 22,232 shares of TNYA common stock.
- Estimated aggregate market value of the proposed sale is approximately $15,778.
- Shares were acquired from restricted stock unit vesting on August 17, 2026.
- The sale is planned through Morgan Stanley Smith Barney.
- The filing date is August 17, 2026, with no specific expiration date provided.
Financial Impact
Proposed sale of 22,232 shares valued at ~$15,778, representing a small fraction of the company's $163M market cap.
Risk Factors
- Insider selling by an officer/director may signal lack of confidence in near-term prospects.
- The proposed sale could be executed ahead of potential negative catalysts or earnings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001193125-26-354513 |
| Document: 0001193125-26-354513-index.html | 0001193125-26-354513 |
| Document: 0001193125-26-354513.txt | 0001193125-26-354513 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | DEFA14A | $0.3945 | awaiting T+60 | — | $0.3989 (+1.12%) |
Oct 23, 2026 3d ago | DEF 14A | $0.3850 | awaiting T+60 | — | $0.3989 (−3.61%) |
Aug 17, 2026 10w ago | 144 | $0.6990 | awaiting T+60 | — | $0.3989 (+42.93%) |
Jul 2, 2026 16w ago | 8-K | $0.7869 $0.5898 | ▼ −25.05% | ▼ −28.62% | $0.3989 (−49.31%) |
Jun 29, 2026 17w ago | 8-K | $0.7349 $0.6822 | ▼ −7.17% | ▼ −11.56% | $0.3989 (−45.72%) |
Jun 12, 2026 19w ago | Institutional Cluster | $0.7118 $0.6634 | ▲ +6.80% | ▲ +10.06% | $0.3989 (+43.96%) |
May 29, 2026 21w ago | 8-K | $0.8700 $0.7014 | ▼ −19.38% | ▼ −20.61% | $0.3989 (−54.15%) |
May 19, 2026 22w ago | Insider Cluster | $0.8080 $0.7281 | ▼ −9.89% | ▼ −14.89% | $0.3989 (−50.63%) |
Apr 16, 2026 27w ago | DEFA14A | $0.7470 $0.8365 | ▲ +11.98% | ▲ +4.94% | $0.3989 (−46.60%) |
Mar 11, 2026 32w ago | 8-K | $0.8930 $0.7280 | ▼ −18.48% | ▼ −29.17% | $0.3989 (−55.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers